Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer.
about
Capecitabine for ER-positive versus ER-negative breast cancerAnthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials.Surviving metastatic breast cancer for 18 years: a case report and review of the literature.
P2860
Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Predictive factors for efficac ...... with metastatic breast cancer.
@en
Predictive factors for efficac ...... with metastatic breast cancer.
@nl
type
label
Predictive factors for efficac ...... with metastatic breast cancer.
@en
Predictive factors for efficac ...... with metastatic breast cancer.
@nl
prefLabel
Predictive factors for efficac ...... with metastatic breast cancer.
@en
Predictive factors for efficac ...... with metastatic breast cancer.
@nl
P2093
P1476
Predictive factors for efficac ...... with metastatic breast cancer.
@en
P2093
Kiyohiko Hatake
Masaaki Matsuura
Masaru Ushijima
Nahomi Tokudome
Shunji Takahashi
Takuji Iwase
Tomo Osako
Tsutomu Sugihara
Yoshinori Ito
P2888
P304
P356
10.1007/S00280-008-0806-7
P577
2008-08-01T00:00:00Z